Page 233 - ANUAL REPORT MOH 2017
P. 233

Table 22
                              List of HTA, CPGs, and TechBrief reports produced in 2017

                 Health Technology Assessment Reports              Clinical Practice Guidelines
              1.  Chinese Herbal Medicine as an adjunct for the  1.  Management of Colorectal Carcinoma
                 management of fatigue and muscle weakness  2.  Management of Asthma in Adults
                 in cancer patients receiving chemotherapy  3.  Management of Diabetes in Pregnancy
              2.  Low dose CT scan for Lung Cancer Screening  4.  Management of Glaucoma (Second Edition)
              3.  Quit Smoking Interventions                5.  Primary  and  Secondary  Prevention  of
              4.  Microinvasive/Minimally Invasive Glaucoma    Cardiovascular Disease
                 Surgery (MIGS)                             6.  Management of Dyslipidaemia (5th Edition)
                           TechBrief Reports                7.  Management of Osteoporosis (Third Edition)
              1.  Padeliporfin Vascular Targeted
                   Photodynamic Therapy for Localised
                   Prostate Cancer
              2.  Glucowise
              3.  Malaria Vaccine
              4.  Oral HIF-PHI (Hypoxia Inducible Factor-
                   Prolyl Hydroxylase Inhibitor) for the
                    treatment of anaemia in chronic kidney disease

             Source: MaHTAS, MoH

                                                      Table 23
                      Technology Review Reports Produced in 2017 based on Recommendations
                                                                  Technologies Recommended For
                       Recommended Technologies
                                                                         Research Purpose
              1.  Sunitinib/ Pazopanib as First-Line Treatment &  1.  Platelet Rich Plasma (PRP) for Treatment
                  Axitinib/ Everolimus as Second-Line Treatment for   of Osteoarthritis (OA) - An Update
                  Metastatic Renal Cell Carcinoma and Economic     Not recommended technologies
                  Evaluation
              2.  Trastuzumab as An Adjuvant Therapy for Early   1.  Oral Folic Acid for Chronic Kidney
                  Breast Cancer and Economic Evaluation            Disease (CKD)
              3.  Transcranial Direct Current Stimulation for Stroke   2.  Low  Molecular  Weight  Heparin
                  Rehabilitation                                   (LMWH) as A Prophylaxis for Venous
              4.  Male Circumcision                                Thromboembolism (VTE) in Pregnancy
              5.  Integrated Notification for Tuberculosis         and Postpartum
              6.  Ioidine-131-Rituximab Radioimmunotherapy for   3.  The Effect of Marketing of Unhealthy
                  Non-Hodgkin’s Lymphoma                           Food and Beverages to Children
              7.  Selective Internal Radiation Therapy (SIRT) Using   4.  Trastuzumab for  Metastatic Breast
                  Yttrium-90 Microspheres for HCC                  Cancer and Economic Evaluation
              8.  Clinical  Hypnosis/Hypnotherapy  for  Pain   5.  Hyperbaric Oxygen Therapy (HBOT) -
                  Management, Depression, Anxiety and Addiction    An update
              9.  Platelet Rich Plasma (PRP) for Facial Rejuvenation  6.  Autohemotherapy (Autologous blood
              10. Intra-Arterial Chemotherapy (IAC) Treatment for   transfusion) Ozone Therapy - An update
                  Pancreatic Cancer
             Source: MaHTAS, MoH






                 232    ANNUAL REPORT 2017     MINISTRY OF HEALTH MALAYSIA
   228   229   230   231   232   233   234   235   236   237   238